#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	15342	16S	1529	1529	100.0	16S.l6.c17.ctg.1	2560	739.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1615	1615	C	1035	C	1035	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26602	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4031	822.8	0	.	n	.	0	T695C	SNP	695	695	T	1291	1291	C	998	C,T,A	996,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26602	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4031	822.8	0	.	n	.	0	G1337A	SNP	1337	1337	G	1933	1933	A	1138	A,G	1137,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26602	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4031	822.8	0	.	n	.	0	T1971C	SNP	1971	1971	T	2567	2567	C	883	C	883	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26602	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4031	822.8	1	SNP	n	A2045G	0	.	.	2045	2045	A	2641	2641	A	773	A,C,G	770,2,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26602	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4031	822.8	1	SNP	n	C2597T	0	.	.	2597	2597	C	3193	3193	C	1034	C,A	1033,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26602	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4031	822.8	0	HET	.	.	.	C2403T,G	.	2403	2403	C	2999	2999	C	902	C,T,G	715,186,1	.	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	2150	folP	855	855	100.0	folP.l6.c4.ctg.1	1932	138.8	1	SNP	p	R229S	1	.	.	685	687	AGC	1228	1230	AGC	213;211;212	A,C;G;C	212,1;211;212	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5266	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3827	171.6	1	SNP	p	S91F	1	.	.	271	273	TTC	754	756	TTC	208;211;211	T;T,C;C	208;210,1;211	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5266	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3827	171.6	1	SNP	p	G95N	0	.	.	283	285	GGC	766	768	GGC	208;206;208	G,T;G,T;C	207,1;205,1;208	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5266	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3827	171.6	1	SNP	p	D95G	1	.	.	283	285	GGC	766	768	GGC	208;206;208	G,T;G,T;C	207,1;205,1;208	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	2066	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1676	153.4	1	SNP	p	G45D	0	.	.	133	135	GGC	652	654	GGC	251;250;249	G;G,T;C	251;249,1;249	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1186	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1388	106.5	0	.	n	.	0	A197.	DEL	197	197	A	789	789	A	233	A	233	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5236	parC	2304	2304	100.0	parC.l6.c30.ctg.1	3298	198.1	1	SNP	p	D86N	0	.	.	256	258	GAC	711	713	GAC	229;227;224	G;A;C	229;227;224	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5236	parC	2304	2304	100.0	parC.l6.c30.ctg.1	3298	198.1	1	SNP	p	R87I	0	.	.	259	261	CGT	714	716	CGT	226;229;232	C;G;T,C	226;229;231,1	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5236	parC	2304	2304	100.0	parC.l6.c30.ctg.1	3298	198.1	1	SNP	p	S87R	1	.	.	259	261	CGT	714	716	CGT	226;229;232	C;G;T,C	226;229;231,1	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5236	parC	2304	2304	100.0	parC.l6.c30.ctg.1	3298	198.1	1	SNP	p	R87W	0	.	.	259	261	CGT	714	716	CGT	226;229;232	C;G;T,C	226;229;231,1	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5236	parC	2304	2304	100.0	parC.l6.c30.ctg.1	3298	198.1	1	SNP	p	S88P	0	.	.	262	264	TCC	717	719	TCC	232;231;230	T;C;C	232;231;230	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4194	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3041	171.9	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1764	1766	GGC	204;205;207	G;G;C	204;205;207	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	4088	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2709	188.1	1	SNP	p	A311V	0	.	.	931	933	GCA	1408	1410	GCA	202;203;200	G,A;C,G;A	201,1;202,1;200	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4088	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2709	188.1	1	SNP	p	I312M	0	.	.	934	936	ATC	1411	1413	ATC	201;201;197	A,C;T;C,T	200,1;201;195,2	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4088	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2709	188.1	1	SNP	p	V316T	0	.	.	946	948	GTG	1423	1425	GTG	200;202;202	G,C;T,G;G,T	199,1;200,2;201,1	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4088	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2709	188.1	1	SNP	p	V316P	0	.	.	946	948	GTG	1423	1425	GTG	200;202;202	G,C;T,G;G,T	199,1;200,2;201,1	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4088	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2709	188.1	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1927	1929	ACC	287;285;284	A;C;C,T,A	287;285;282,1,1	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4088	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2709	188.1	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1981	1983	GCG	251;250;248	G,C;C;G	250,1;250;248	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4088	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2709	188.1	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1981	1983	GCG	251;250;248	G,C;C;G	250,1;250;248	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4088	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2709	188.1	1	SNP	p	G543S	1	.	.	1627	1629	AGC	2104	2106	AGC	224;225;227	A,C;G;C	223,1;225;227	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4088	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2709	188.1	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2113	2115	GGC	232;238;239	G;G;C,G	232;238;238,1	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4088	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2709	188.1	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2131	2133	CCG	246;247;246	C,T,G,A;C;G,A	243,1,1,1;247;245,1	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5802	ponA	2397	2397	100.0	ponA.l6.c17.ctg.1	3476	208.0	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1783	1785	CCG	257;258;258	C,A;C;G	256,1;258;258	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2258	porA	1146	1146	99.91	porA.l6.c17.ctg.1	2154	130.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	724	724	C	177	C	177	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	292	porB1a	984	158	93.04	porB1a.l15.c4.ctg.4	158	50.6	0	.	p	.	0	V258L	NONSYN	772	774	GTA	14	16	TTA	28;31;33	T;T;A	28;31;33	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	292	porB1a	984	158	93.04	porB1a.l15.c4.ctg.4	158	50.6	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	59	61	CAT	64;64;64	C;A;T,G	64;64;63,1	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	292	porB1a	984	158	93.04	porB1a.l15.c4.ctg.4	158	50.6	0	.	p	.	0	D274S	NONSYN	820	822	GAT	62	64	AGT	64;64;64	A;G;T	64;64;64	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	292	porB1a	984	158	93.04	porB1a.l15.c4.ctg.4	158	50.6	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	71	73	TAC	64;64;64	T;A;C	64;64;64	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	2970	porB1b	1041	1041	97.31	porB1b.l15.c30.ctg.1	1777	205.5	0	.	p	.	0	V75I	NONSYN	223	225	GTT	596	598	ATT	264;266;268	A,C;T;T	263,1;266;268	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	2970	porB1b	1041	1041	97.31	porB1b.l15.c30.ctg.1	1777	205.5	0	.	p	.	0	T89S	NONSYN	265	267	ACC	638	640	AGC	273;273;274	A;G;C,T,A	273;273;272,1,1	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	2970	porB1b	1041	1041	97.31	porB1b.l15.c30.ctg.1	1777	205.5	0	.	p	.	0	V98I	NONSYN	292	294	GTC	665	667	ATC	248;248;247	A,C;T,G;C,T	247,1;247,1;246,1	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	2970	porB1b	1041	1041	97.31	porB1b.l15.c30.ctg.1	1777	205.5	0	.	p	.	0	.	MULTIPLE	358	359	AA	730	731	CG	239;238	C;G,C	239;237,1	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	2970	porB1b	1041	1041	97.31	porB1b.l15.c30.ctg.1	1777	205.5	0	.	p	.	0	.	MULTIPLE	361	362	GA	733	735	CAG	237;239;237	C;A,C;G,A	237;238,1;236,1	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	2970	porB1b	1041	1041	97.31	porB1b.l15.c30.ctg.1	1777	205.5	0	.	p	.	0	N122K	NONSYN	364	366	AAC	737	739	AAA	226;227;228	A,C;A;A	225,1;227;228	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	2970	porB1b	1041	1041	97.31	porB1b.l15.c30.ctg.1	1777	205.5	0	.	p	.	0	F131Y	NONSYN	391	393	TTT	764	766	TAT	243;243;243	T;A;T,G	243;243;242,1	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	2970	porB1b	1041	1041	97.31	porB1b.l15.c30.ctg.1	1777	205.5	0	.	p	.	0	N134E	NONSYN	400	402	AAT	773	775	GAG	238;239;240	G;A;G	238;239;240	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	2970	porB1b	1041	1041	97.31	porB1b.l15.c30.ctg.1	1777	205.5	0	.	p	.	0	V135L	NONSYN	403	405	GTG	776	778	CTT	242;242;244	C;T,C;T	242;241,1;244	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	2970	porB1b	1041	1041	97.31	porB1b.l15.c30.ctg.1	1777	205.5	0	.	p	.	0	G140K	NONSYN	418	420	GGA	791	793	AAA	257;260;259	A;A;A	257;260;259	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	2970	porB1b	1041	1041	97.31	porB1b.l15.c30.ctg.1	1777	205.5	0	.	p	.	0	Q143E	NONSYN	427	429	CAA	800	802	GAA	252;252;253	G;A;A,C	252;252;252,1	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	2970	porB1b	1041	1041	97.31	porB1b.l15.c30.ctg.1	1777	205.5	0	.	p	.	0	A213S	NONSYN	637	639	GCA	1010	1012	TCA	265;267;269	T;C,A;A	265;265,2;269	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	2970	porB1b	1041	1041	97.31	porB1b.l15.c30.ctg.1	1777	205.5	0	.	p	.	0	Y255W	NONSYN	763	765	TAC	1136	1138	TGG	272;273;272	T;G,A;G	272;272,1;272	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	2970	porB1b	1041	1041	97.31	porB1b.l15.c30.ctg.1	1777	205.5	0	.	p	.	0	R256H	NONSYN	766	768	CGT	1139	1141	CAT	270;269;266	C;A;T	270;269;266	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	2970	porB1b	1041	1041	97.31	porB1b.l15.c30.ctg.1	1777	205.5	0	.	p	.	0	E326A	NONSYN	976	978	GAA	1349	1351	GCA	260;257;258	G,T;C;A	259,1;257;258	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	2970	porB1b	1041	1041	97.31	porB1b.l15.c30.ctg.1	1777	205.5	1	SNP	p	G120K	1	.	.	358	360	AAG	730	732	CGG	239;238;236	C;G,C;G,A	239;237,1;235,1	porB1b.WHO_X_02194c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	2970	porB1b	1041	1041	97.31	porB1b.l15.c30.ctg.1	1777	205.5	1	SNP	p	A121D	1	.	.	361	363	GAC	733	736	CGC	237;237;232	C;G,A;C	237;236,1;232	porB1b.WHO_X_02194c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	2970	porB1b	1041	1041	97.31	porB1b.l15.c30.ctg.1	1777	205.5	1	SNP	p	D121N	0	.	.	361	363	GAC	733	736	CGC	237;237;232	C;G,A;C	237;236,1;232	porB1b.WHO_X_02194c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10752	rpoB	4179	4179	99.98	rpoB.l6.c17.ctg.1	5264	254.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1582	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1446	136.5	1	SNP	p	V57M	1	.	.	169	171	ATG	758	760	ATG	285;287;284	A;T;G	285;287;284	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
